2015 | Combinatorial TGF-beta attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells | 신윤용; 김대기; 임우성 | Article |
2015 | Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells | 신윤용; 김대기; 임우성 | Article |
2014 | EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis | 신윤용; 김대기 | Article |
2014 | 4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-β type i receptor kinase | 신윤용; 김대기 | Article |
2014 | An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition | 신윤용; 김대기 | Article |
2014 | Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin- 2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent | 신윤용; 이화정; 김대기 | Article |
2014 | EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling | 신윤용; 김대기; 우현애 | Article in Press |
2013 | Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes | 김대기 | Article |
2013 | IN-1233-eluting covered metallic stent to prevent hyperplasia: Experimental study in a rabbit esophageal model | 김대기 | Article |
2013 | Transforming growth factor-β1 receptor inhibition preserves glomerulotubular integrity during ureteral obstruction in adults but worsens injury in neonatal mice | 김대기 | Article |